Search Tag: SABCS 2022
New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test
2022 06 Dec
The Breast Cancer Index Test Is the First Biomarker to Predict Treatment Benefit in the SOFT Trial Hologic , Inc. and its subsidiary, Biotheranostics, Inc., announced new study data showing that the Breast Cancer Index test identified which premenopausal patients with early-stage, hormone-receptor positive (HR+) breast cancer benefited from... Read more
